Melanoma Monday: A Review of the MSLT-II Trial and Completion Lymph Node Dissection

May 2, 2022

On Melanoma Monday, the first Monday in May which has been designated as a day to raise awareness about skin cancer, Targeted Oncology™ published an article authored by Dr. Katherine Poruk, surgical oncologist at Cancer Treatment Centers of America® (CTCA) Atlanta. In this article Dr. Poruk reviews the use of complete axillary lymph node dissection and the Multicenter Selective Lymphadenectomy Trial II.

Read more here

About Cancer Treatment Centers of America
Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.